These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34462055)

  • 21. Restoring Tip60 HAT/HDAC2 Balance in the Neurodegenerative Brain Relieves Epigenetic Transcriptional Repression and Reinstates Cognition.
    Panikker P; Xu SJ; Zhang H; Sarthi J; Beaver M; Sheth A; Akhter S; Elefant F
    J Neurosci; 2018 May; 38(19):4569-4583. PubMed ID: 29654189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
    Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
    Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise and pharmacological inhibition of histone deacetylase improves cognitive function accompanied by an increase of gene expressions crucial for neuronal plasticity in the hippocampus.
    Kitahara M; Inoue T; Mani H; Takamatsu Y; Ikegami R; Tohyama H; Maejima H
    Neurosci Lett; 2021 Apr; 749():135749. PubMed ID: 33610667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tubulin acetylation: responsible enzymes, biological functions and human diseases.
    Li L; Yang XJ
    Cell Mol Life Sci; 2015 Nov; 72(22):4237-55. PubMed ID: 26227334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postnatal Ethanol Exposure Activates HDAC-Mediated Histone Deacetylation, Impairs Synaptic Plasticity Gene Expression and Behavior in Mice.
    Shivakumar M; Subbanna S; Joshi V; Basavarajappa BS
    Int J Neuropsychopharmacol; 2020 May; 23(5):324-338. PubMed ID: 32170298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools.
    Anne-Laurence B; Caroline R; Irina P; Jean-Philippe L
    Subcell Biochem; 2007; 41():263-93. PubMed ID: 17484132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53.
    Mrakovcic M; Bohner L; Hanisch M; Fröhlich LF
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural Agents-Mediated Targeting of Histone Deacetylases.
    Farooqi AA; Naqvi SK; Perk AA; Yanar O; Tabassum S; Ahmad MS; Mansoor Q; Ashry MS; Ismail M; Naoum GE; Arafat WO
    Arch Immunol Ther Exp (Warsz); 2018 Feb; 66(1):31-44. PubMed ID: 28852775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis.
    Chen PJ; Huang C; Meng XM; Li J
    Biochimie; 2015 Sep; 116():61-9. PubMed ID: 26116886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered protein acetylation in polyglutamine diseases.
    Bodai L; Pallos J; Thompson LM; Marsh JL
    Curr Med Chem; 2003 Dec; 10(23):2577-87. PubMed ID: 14529472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone acetylation and the cell-cycle in cancer.
    Wang C; Fu M; Mani S; Wadler S; Senderowicz AM; Pestell RG
    Front Biosci; 2001 Apr; 6():D610-29. PubMed ID: 11282573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone acetylation in neuronal (dys)function.
    Bonnaud EM; Suberbielle E; Malnou CE
    Biomol Concepts; 2016 May; 7(2):103-16. PubMed ID: 27101554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone Deacetylase Inhibition via RGFP966 Releases the Brakes on Sensory Cortical Plasticity and the Specificity of Memory Formation.
    Bieszczad KM; Bechay K; Rusche JR; Jacques V; Kudugunti S; Miao W; Weinberger NM; McGaugh JL; Wood MA
    J Neurosci; 2015 Sep; 35(38):13124-32. PubMed ID: 26400942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Class I Histone Deacetylase Inhibition by Tianeptinaline Modulates Neuroplasticity and Enhances Memory.
    Zhao WN; Ghosh B; Tyler M; Lalonde J; Joseph NF; Kosaric N; Fass DM; Tsai LH; Mazitschek R; Haggarty SJ
    ACS Chem Neurosci; 2018 Sep; 9(9):2262-2273. PubMed ID: 29932631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of naturally occurring histone deacetylase inhibitors.
    Kim B; Hong J
    Curr Top Med Chem; 2015; 14(24):2759-82. PubMed ID: 25487010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tescalcin is a potential target of class I histone deacetylase inhibitors in neurons.
    Takamatsu G; Katagiri C; Tomoyuki T; Shimizu-Okabe C; Nakamura W; Nakamura-Higa M; Hayakawa T; Wakabayashi S; Kondo T; Takayama C; Matsushita M
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1327-1333. PubMed ID: 27939885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
    Li G; Jiang H; Chang M; Xie H; Hu L
    J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.
    Abel T; Zukin RS
    Curr Opin Pharmacol; 2008 Feb; 8(1):57-64. PubMed ID: 18206423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.